When conducting research at MultiCare the investigator has these responsibilities:
If you are conducting a clinical trial you should be well versed in Good Clinical Practices (GCP). The MultiCare IRB expects all investigators to follow the guidance set forth by the Federal Drug Administration when doing clinical research using a drug under an IND or a device not approved for general use.
Federal Drug Administration (FDA)
Food and Drug Administration (FDA)
Protection of Human Subjects - FDA Regulations, 21 CFR, Part 50
Institutional Review Boards - FDA Regulations, 21 CFR Part 56
Guidance for IRBs and Clinical Investigators
Humanitarian Device Exemption
Office for Human Research Protections (OHRP)
OHRP
Federal Regulations for Research with Human Subjects - Department of Health and Human Services, 45 CFR, Part 46 Including Subpart D, Additional DHHS Protections for Children Involved as Subjects in Research IRB Guidebook for Protecting Human Research Subjects
The Belmont Report
The World Medical Association Declaration of Helsinki